Le Lézard
Classified in: Science and technology, Covid-19 virus
Subjects: Product/Service, Webcast

QGenda Launches Clinical Capacity Analytics Tool, QGenda Insights


QGenda, the leading innovator in clinical capacity and workforce management solutions, announced the availability of QGenda Insights. The platform is the only labor analytics solution to support resource optimization and clinical productivity improvements for health systems, academic medical centers, hospitals, and practice groups. Aggregating scheduling and labor data across departments, the solution provides the immediate visibility into workforce utilization and availability that is critical to adapting in the current environment.

The COVID-19 pandemic has heightened the need to understand clinical capacity and empower leadership teams with the necessary data to act quickly to manage a potential patient surge. With QGenda Insights, organizations can understand provider capacity across the enterprise and identify providers to support increased coverage based on demand. As a result, health systems can ensure they are appropriately staffed and prepared for continued waves of COVID-19 patients in addition to the standard services they provide.

The current environment has also accelerated the financial challenges healthcare organizations already faced. Now, more than ever, organizations are focused on implementing effective resource management to manage costs. "Hospital and health system payrolls are often the largest expenditure for the organization and one of the first places organizations examine for inefficiencies. Ensuring that physician and clinician utilization is optimized is critical to the bottom line of the health system. QGenda Insights is the tool to understand how to optimize that coverage. It's more important now than ever," said Rich Miller, Chief Strategy Officer of QGenda.

QGenda Insights uses QGenda's proprietary data transformation engine and state-of-the-art visualization tools to provide healthcare leaders with a comprehensive understanding of clinical capacity, ensuring clinical staffing aligns with financial objectives and patient volume. The solution provides:

QGenda CEO Greg Benoit said, "We recognize that hospital and health system leadership is being inundated with data about their organization, but they need near real-time information about their current and future clinical capacity so that they can make quick, informed decisions. With QGenda Insights, hospitals and health systems can maximize productivity of their clinical workforce using the data that is already in their QGenda platform."

QGenda Insights is the newest addition to QGenda's clinical capacity management platform that includes advanced provider and staff scheduling, on-call management, time-tracking, and compensation management. The QGenda platform is used by over 3,000 healthcare organizations including enterprise health systems, hospitals, academic medical centers, and physician groups.

To learn more about QGenda Insights and the impact it will have on clinical resource allocation and financial outcomes for organizations, join us for our webinar Using Workforce Analytics to Improve Clinical Capacity on July 15 at 1:00 pm ET / 10:00 am PT.

About QGenda LLC

QGenda is the leading innovator of provider scheduling, clinical capacity management, and labor analytics. Since its launch in 2006, QGenda has grown to serve more than 3,000 organizations in over 30 medical specialties. Leading physician groups, hospitals, academic medical centers, and enterprise health systems use QGenda for their provider scheduling, optimizing their workforce and empowering patient care. QGenda is headquartered in Atlanta, GA with offices in Baltimore, MD, and South Burlington, VT. Learn why 90 of 100 Becker's Greatest Hospitals use QGenda at www.QGenda.com, or follow on Facebook, Instagram, LinkedIn, and Twitter.


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

28 mar 2024
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

28 mar 2024
Boat Rocker Media Inc. ("Boat Rocker" or the "Company") , an independent, integrated global entertainment company, today reported its financial results for the three months ended December 31, 2023 ("fourth quarter" or "Q4") and for the year ended...



News published on and distributed by: